Company intelligence / Profile preview

Arcxis Biosciences

Sunnyvale, California, USA

Ownership: Private
Development stage: Other

Overview

Arcxis Biosciences was a molecular diagnostics company that developed automated sample preparation systems for clinical and research applications. The company's flagship technology, the Xis-Prep system, utilized microfluidics to streamline the extraction and purification of nucleic acids from complex biological samples. By automating these labor-intensive processes, Arcxis aimed to improve the speed and accuracy of molecular testing in fields such as infectious disease and oncology. The company was acquired by Bruker Corporation in 2010 to enhance Bruker's portfolio in the molecular diagnostics and microbiology markets.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Device
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Arcxis Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arcxis Biosciences.

Explore the full profile